Anghel, L.; Stătescu, C.; Șerban, I.-L.; Mărănducă, M.A.; Butcovan, D.; Clement, A.; Bostan, M.; Sascău, R.
The Advantages of New Multimodality Imaging in Choosing the Optimal Management Strategy for Patients with Hypertrophic Cardiomyopathy. Diagnostics 2020, 10, 719.
https://doi.org/10.3390/diagnostics10090719
AMA Style
Anghel L, Stătescu C, Șerban I-L, Mărănducă MA, Butcovan D, Clement A, Bostan M, Sascău R.
The Advantages of New Multimodality Imaging in Choosing the Optimal Management Strategy for Patients with Hypertrophic Cardiomyopathy. Diagnostics. 2020; 10(9):719.
https://doi.org/10.3390/diagnostics10090719
Chicago/Turabian Style
Anghel, Larisa, Cristian Stătescu, Ionela-Lăcrămioara Șerban, Minela Aida Mărănducă, Doina Butcovan, Alexandra Clement, Mădălina Bostan, and Radu Sascău.
2020. "The Advantages of New Multimodality Imaging in Choosing the Optimal Management Strategy for Patients with Hypertrophic Cardiomyopathy" Diagnostics 10, no. 9: 719.
https://doi.org/10.3390/diagnostics10090719
APA Style
Anghel, L., Stătescu, C., Șerban, I.-L., Mărănducă, M. A., Butcovan, D., Clement, A., Bostan, M., & Sascău, R.
(2020). The Advantages of New Multimodality Imaging in Choosing the Optimal Management Strategy for Patients with Hypertrophic Cardiomyopathy. Diagnostics, 10(9), 719.
https://doi.org/10.3390/diagnostics10090719
